Brisk walk may slow down Alzheimer's risk: study

Image
Press Trust of India Washington
Last Updated : Jun 23 2017 | 5:57 PM IST
Taking a brisk walk or engaging in other moderate-intensity physical activities may help slow down the progression of Alzheimer's disease in people who are already at a risk of developing the disorder, a study claims.
Researchers from University of Wisconsin-Madison in the US studied about 93 members of a parental history Alzheimer's risk study group.
They measured the daily physical activity of participants, all of whom were in late middle-age and at high genetic risk for Alzheimer's disease, but presently show no cognitive impairment.
Activity levels were measured for one week, quantified, and analysed. This approach allowed researchers to determine the amount of time each subject spent engaged in light, moderate, and vigorous levels of physical activity.
Light physical activity is equivalent to walking slowly, while moderate is equivalent to a brisk walk and vigorous a strenuous run.
Data on the intensities of physical activity were then statistically analysed to determine how they corresponded with glucose metabolism - a measure of neuronal health and activity - in areas of the brain known to have depressed glucose metabolism in people with Alzheimer's disease.
Researchers measured brain glucose metabolism using a specialised imaging technique called 18F-fluorodeoxyglucose positron emission tomography (FDG-PET).
They found moderate physical activity was associated with healthier (greater levels of) glucose metabolism in all brain regions analysed.
Researchers also noted a step-wise benefit: subjects who spent at least 68 minutes per day engaged in moderate physical activity showed better glucose metabolism profiles than those who spent less time.
"While many people become discouraged about Alzheimer's disease, these results suggest that engaging in moderate physical activity may slow down the progression of the disease," said Ryan Dougherty from University of Wisconsin- Madison.
The study was published in Journal of Alzheimer's Disease.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 23 2017 | 5:57 PM IST

Next Story